Abstracts
Résumé
Le foie, le rein et les tissus du système gastro-intestinal sont reconnus comme des sites majeurs qui conjuguent les composés exogènes en dérivés glucuronides par l’intermédiaire des UDP-glucuronosyltransférases (UGT). C’est un mécanisme extrêmement important dans l’élimination de la plupart de ces composés du corps humain. Des études récentes ont montré qu’en plus du foie et du rein, plusieurs glandes comme la prostate et la peau présentent un mécanisme de détoxification similaire, mais dont le but serait d’inactiver les stéroïdes. Une diminution d’activité des enzymes qui inactivent les stéroïdes pourrait provoquer une accumulation excessive du substrat et avoir des conséquences délétères sur ces tissus.
Summary
Liver, kidney, and gastrointestinal tissues are well known to express UDP-glucuronosyltransférase (UGT) enzymes which conjugate exogenous compounds. This mechanism is extremely important to eliminate several compounds from the body. Recent studies have shown that, in addition to the liver and kidney, a large number of tissues, namely the prostate and skin, also express UGT which are capable of inactivating steroids. This mechanism may be a means to modulate the action of steroids in these tissues.
Appendices
Références
- 1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999; 286: 487-91.
- 2. Tukey RH, Strassburg CP. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Phamacol 2001; 59: 405-14.
- 3. Lévesque E, Turgeon D, Carrier JS, Montminy V, Beaulieu M, Bélanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuonosyltransferase. Biochemistry 2001; 40: 3869-81.
- 4. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 1999; 31: 817-99.
- 5. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrinol Rev 2003; 24: 152-82.
- 6. Bélanger A, Brochu M, Cliche J. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J ClinEndocrinol Metab 1986; 62: 812-5.
- 7. Brochu M, Bélanger A, Tremblay RR. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertil Steril 1987; 48: 948-53.
- 8. Green MD, Tephly TR. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Disp 1996; 24: 356-63.
- 9. Albert C, Vallée M, Beaudry G, Bélanger A, Hum DW. The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen conjugating enzymes. Endocrinology 1999; 140: 3292-302.
- 10. Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 1998; 248: 44-50.
- 11. Carrier JS, Turgeon D, Journeault K, Hum DW, Bélanger A. Isolation and characterization of the human UGT2B7 gene. BiochemBiophys Res Commun 2000; 272: 616-21.
- 12. Turgeon D, Carrier JS, Lévesque É, Hum DW, Bélanger A. Relative enzymatic activity, protein stability and tissue distribution of human steroid metabolizing UGT2B subfamily members. Endocrinology 2001; 142: 778-87.
- 13. Radominska-Pandya A, Little JM, Czernik PJ. Human UDP-glucuronosyltransferase 2B7. Curr Drug Metab 2001; 2: 283-98.
- 14. Gestl SA, Green MD, Shearer DA, Frauenhoffer E, Tephly TR, Weisz J. Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am J Pathol 2002; 160: 1467-79.
- 15. Coumoul X, Barouki R. Génotoxicité des métabolites des oestrogènes et cancers. Med Sci 2002; 18: 86-90.
- 16. Turgeon D, Carrier JS, Lévesque E, Beatty BG, Bélanger A, Hum DW. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 2000; 295: 489-504.
- 17. Lévesque E, Beaulieu M, Green MD, Tephly TR, Bélanger A, Hum DW. Isolation and characterization of UGT2B15(Y85): A UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 1997; 7: 317-25.
- 18. Beaulieu M, Lévesque E, Hum DW, Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 1996; 271: 22855-62.
- 19. Horton R. Dihydrotestosterone is a peripheral paracrine hormone. J Androl 1992; 13: 23-7.
- 20. Bélanger A, Couture J, Caron S, Roy R. Determination of non-conjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann NY Acad Sci 1990; 595: 251-9.
- 21. El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunohistochemistry. Endocrinology 1999; 140: 1481-91.
- 22. Barbier O, Lapointe H, El Alfy M, Hum DW, Belanger A. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 2000; 85: 4819-26.
- 23. MacLeod SL, Nowell S, Plaxco J, Lang NP. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 2000; 7: 777-82.
- 24. Gsur A, Preyer M, Haidinger G, et al. A polymorphism in the UDP-glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. CancerEpidemiol Biomarkers Prev 2002; 11: 497-8.